Abzena has appointed Elaine Sapinoso as senior vice president of global quality to support the addition of new manufacturing suites at 2000L scale at its San Diego, CA site, complex small molecule manufacturing capabilities at its Bristol, PA site, and integration of its gene to GMP services.
 
In this role, Ms. Sapinoso is responsible for the oversight of quality assurance, quality control, and analytical development departments. She is also responsible for regulatory compliance across the Abzena sites reporting directly to Jonathan Goldman, chief executive officer.
 
“I am delighted to welcome Elaine as our global head of quality,” said Dr. Goldman. “Elaine brings world-class expertise in GMP quality oversight from development through to commercial scale for both large and small molecules. Her experience will help us make our new facilities available to our customers, and allow us to implement commercial scale manufacturing.”
 
Prior to joining Abzena, Ms. Sapinoso served in senior roles at global contract manufacturing organizations. She was formerly vice president of quality and regulatory at Aji Bio-Pharma where she was responsible for the quality in drug substance, drug product and testing operations from early clinical through commercial phase.